Implications in Cancer of Nuclear Micro RNAs, Long Non-Coding RNAs, and Circular RNAs Bound by PRC2 and FUS

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Mar 13

PMID 38473229

Authors

Guruprasadh Swaminathan

Diana G Rogel-Ayala

Amine Armich

Guillermo Barreto

Affiliations

Soon will be listed here.

Abstract

The eukaryotic genome is mainly transcribed into non-coding RNAs (ncRNAs), including different RNA biotypes, such as micro RNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), among others. Although miRNAs are assumed to act primarily in the cytosol, mature miRNAs have been reported and functionally characterized in the nuclei of different cells. Further, lncRNAs are important regulators of different biological processes in the cell nucleus as part of different ribonucleoprotein complexes. CircRNAs constitute a relatively less-characterized RNA biotype that has a circular structure as result of a back-splicing process. However, circRNAs have recently attracted attention in different scientific fields due to their involvement in various biological processes and pathologies. In this review, we will summarize recent studies that link to cancer miRNAs that have been functionally characterized in the cell nucleus, as well as lncRNAs and circRNAs that are bound by core components of the polycomb repressive complex 2 (PRC2) or the protein fused in sarcoma (FUS), highlighting mechanistic aspects and their diagnostic and therapeutic potential.

Citing Articles

Mechanisms and technologies in cancer epigenetics.

Sherif Z, Ogunwobi O, Ressom H Front Oncol. 2025; 14:1513654.

PMID: 39839798 PMC: 11746123. DOI: 10.3389/fonc.2024.1513654.

References

Liu Y, Yang Y, Wang X, Yin S, Liang B, Zhang Y . Function of microRNA‑124 in the pathogenesis of cancer (Review). Int J Oncol. 2023; 64(1). PMC: 10705041. DOI: 10.3892/ijo.2023.5594. View

Yan J, Dutta B, Hee Y, Chng W . Towards understanding of PRC2 binding to RNA. RNA Biol. 2019; 16(2):176-184. PMC: 6380335. DOI: 10.1080/15476286.2019.1565283. View

Zhang D, Sun Q, Zou X, Song Y, Li W, Guo Z . Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. J Exp Clin Cancer Res. 2020; 39(1):229. PMC: 7596966. DOI: 10.1186/s13046-020-01748-y. View

Michas A, Michas V, Anagnostou E, Galanopoulos M, Tolia M, Tsoukalas N . The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review. Glob Med Genet. 2023; 10(4):315-323. PMC: 10665125. DOI: 10.1055/s-0043-1777094. View

Roush S, Slack F . The let-7 family of microRNAs. Trends Cell Biol. 2008; 18(10):505-16. DOI: 10.1016/j.tcb.2008.07.007. View

Mirzaei S, Gholami M, Hushmandi K, Hashemi F, Zabolian A, Canadas I . The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol. 2022; 15(1):18. PMC: 8892735. DOI: 10.1186/s13045-022-01235-1. View

Hendrickson D, Kelley D, Tenen D, Bernstein B, Rinn J . Widespread RNA binding by chromatin-associated proteins. Genome Biol. 2016; 17:28. PMC: 4756407. DOI: 10.1186/s13059-016-0878-3. View

Kim J, Lee Y, Lu X, Song B, Fong K, Cao Q . Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator. Cell Rep. 2018; 25(10):2808-2820.e4. PMC: 6342284. DOI: 10.1016/j.celrep.2018.11.035. View

Iwasaki Y, Koseki H, Ito S . In preprints: revisiting RNA in PRC2. Development. 2023; 150(22). DOI: 10.1242/dev.202440. View

10.

ElZallat M, Hassan M, Elkramani N, Aboushousha T, Abdellatif A, Helal N . Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma. Heliyon. 2023; 9(4):e15288. PMC: 10123146. DOI: 10.1016/j.heliyon.2023.e15288. View

11.

Rasko J, Wong J . Nuclear microRNAs in normal hemopoiesis and cancer. J Hematol Oncol. 2017; 10(1):8. PMC: 5217201. DOI: 10.1186/s13045-016-0375-x. View

12.

King O, Gitler A, Shorter J . The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012; 1462:61-80. PMC: 3372647. DOI: 10.1016/j.brainres.2012.01.016. View

13.

Yan L, Yue C, Xu Y, Jiang X, Zhang L, Wu J . Prognostic Value and Molecular Regulatory Mechanism of MSTO2P in Hepatocellular Carcinoma: A Comprehensive Study Based on Bioinformatics, Clinical Analysis and in vitro Validation. Onco Targets Ther. 2020; 13:2583-2598. PMC: 7109319. DOI: 10.2147/OTT.S245741. View

14.

Fan Y, Ji C, Xu B, Fan H, Cheng Z, Zhu X . Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis. Clin Chim Acta. 2017; 468:10-16. DOI: 10.1016/j.cca.2017.02.001. View

15.

Lee Y, Jeon K, Lee J, Kim S, Kim V . MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002; 21(17):4663-70. PMC: 126204. DOI: 10.1093/emboj/cdf476. View

16.

Ferguson K, Soydan H, Lee S, Yamanaka A, Freer A, Xie B . Evaluation of the CSEC Community Intervention Project (CCIP) in five U.S. Cities. Eval Rev. 2009; 33(6):568-97. DOI: 10.1177/0193841X09346132. View

17.

Wang Z, Yang L, Wu P, Li X, Tang Y, Ou X . The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin. Mol Cancer. 2022; 21(1):29. PMC: 8785480. DOI: 10.1186/s12943-022-01498-9. View

18.

Rubio K, Dobersch S, Barreto G . Functional interactions between scaffold proteins, noncoding RNAs, and genome loci induce liquid-liquid phase separation as organizing principle for 3-dimensional nuclear architecture: implications in cancer. FASEB J. 2019; 33(5):5814-5822. DOI: 10.1096/fj.201802715R. View

19.

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View

20.

Ai Y, Luo S, Wang B, Xiao S, Wang Y . MiR-126-5p Promotes Tumor Cell Proliferation, Metastasis and Invasion by Targeting TDO2 in Hepatocellular Carcinoma. Molecules. 2022; 27(2). PMC: 8779717. DOI: 10.3390/molecules27020443. View